Physician profile
Lee Kendrick
NPI 1780655167
$4,322.44
in general payments reported to CMS, 2019-2025
38 companies · $880 in 2025
The $880 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $153 · 2021: $596 · 2022: $425 · 2023: $819 · 2024: $781 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,380 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,379.60 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $638.63 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $373.31 | 2019-2025 | Nucala, Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $345.38 | 2019-2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.28 | 2019-2025 | Ofev, Jascayd |
| Merck Sharp & Dohme LLC | $250.73 | 2019-2023 | Recarbrio, Zerbaxa, Dificid |
| Abbvie INC. | $223.55 | 2021-2025 | |
| Stryker Corporation | $183.93 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Grifols USA, LLC | $182.28 | 2019-2025 | Prolastin-C Liquid |
| Inari Medical, INC. | $178.02 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Insmed, INC. | $165.70 | 2022-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $150.00 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $119.61 | 2019-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $119.14 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Paratek Pharmaceuticals, INC. | $111.24 | 2019-2025 | Nuzyra |
| Philips North America LLC | $100.57 | 2022-2024 | (Ak6) Vest Therapy |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $86.68 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $80.34 | 2019-2021 | |
| Genzyme Corporation | $68.81 | 2021-2023 | |
| Shire North American Group INC | $68.22 | 2019 | |
| Genentech USA, INC. | $59.24 | 2019-2021 | |
| La Jolla Pharmaceutical Company | $53.84 | 2021-2024 | Giapreza |
| Mylan Specialty L.P. | $53.81 | 2023-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $48.94 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.51 | 2020-2024 | Glassia |
| Mallinckrodt Enterprises LLC | $40.38 | 2019 | |
| Advanced Respiratory, INC | $37.40 | 2019-2021 | |
| Intuitive Surgical, INC. | $33.34 | 2024 | |
| Csl Behring | $28.92 | 2025 | Hizentra |
| Circassia INC. | $28.01 | 2019 | |
| Ani Pharmaceuticals, INC. | $26.27 | 2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $25.52 | 2025 | Yupelri |
| Electromed, INC. | $23.82 | 2019 | |
| Shionogi INC | $23.48 | 2023 | Fetroja |
| Alexion Pharmaceuticals, INC. | $19.72 | 2022 | |
| Vifor Pharma, INC. | $15.54 | 2024 | Zemaira |
| Janssen Pharmaceuticals, INC | $15.44 | 2023 | Xarelto |
| Theratechnologies INC. | $12.98 | 2019 | |
| Cashflow Solutions, LLC | $8.86 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Kendrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.